Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
The genomic revolution has identified therapeutic targets for a plethora of diseases, creating a need to develop robust technologies for combination drug therapy. In the present work, we describe a self-assembled polymeric nanoparticle (NP) platform to target and control precisely the codelivery of...
Main Authors: | Kolishetti, Nagesh, Dhar, Shanta, Valencia, Pedro Miguel, Lin, Lucy Q., Karnik, Rohit, Lippard, Stephen J., Langer, Robert, Farokhzad, Omid C. |
---|---|
Other Authors: | MIT-Harvard Center for Cancer Nanotechnology Excellence |
Format: | Article |
Language: | en_US |
Published: |
National Academy of Sciences (U.S.)
2013
|
Online Access: | http://hdl.handle.net/1721.1/78881 https://orcid.org/0000-0003-0588-9286 https://orcid.org/0000-0002-2693-4982 https://orcid.org/0000-0002-2640-3006 https://orcid.org/0000-0003-4255-0492 |
Similar Items
-
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
by: Dhar, Shanta, et al.
Published: (2011) -
Microfluidic technologies for accelerating the clinical translation of nanoparticles
by: Langer, Robert, et al.
Published: (2013) -
Microfluidic Platform for Combinatorial Synthesis and Optimization of Targeted Nanoparticles for Cancer Therapy
by: Valencia, Pedro M., et al.
Published: (2015) -
Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles
by: Hanewich-Hollatz, Mikhail H., et al.
Published: (2015) -
Synthesis of size-tunable polymeric nanoparticles enabled by 3D hydrodynamic flow focusing in single-layer microchannels
by: Rhee, Minsoung, et al.
Published: (2013)